Toggle Health Problems and D

Exposing some blood to Ultraviolet light has treated various health problems, then antibiotics came along – April 2016

Ultraviolet blood irradiation: Is it time to remember “the cure that time forgot”? (book chapter)

J Photochem Photobiol B. 2016 Apr; 157: 89–96. 10.1016/j.jphotobiol.2016.02.007
Ximing Wu,a,b,c Xiaoqing Hu,b,c,d and Michael R. Hamblinb,c,e,*
M.R. Hamblin (*) Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02114, USA
Department of Dermatology, Harvard Medical School, Boston, MA 02115, USA
Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA 02139, USA e-mail: Hamblin at helix.mgh.harvard.edu

VitaminDWiki Summary

About 10% of the blood is exposed to UVC for about 10 seconds
Antibiotics and Vaccines worked better for decades
Perhaps UV illumination will be used again after antibiotics can no longer be used
Wonder if UV illumination works by producing Vitamin D in the blood

Vitamin D also works

See also web


Image Image

The above is the author of this publication and below is a quote from his website

  • "The primary purpose of the UltraLux UV device is to reduce signs and symptoms of diseases caused by infection with viruses or bacteria or characterized by excessive inflammation, when other treatment options have proven insufficiently effective."



Viral infections
Bacterial infections
Wound infections
Furunculous and carbunculosis
Inflammatory process: thrombophlebitis, fibrositis, cholecystitis, pancreatitis
Diseases due to inadequate peripheral circulation
Varicose or diabetic ulcers
Peripheral atherosclerosis
Vascular headache
Non-healing wounds and delayed union fractures
Rheumatoid arthritis and other autoimmune diseases


Destruction of fungal, viral and bacterial growth
Improves circulation and decreases platelet aggregation
Improves circulation by dilating blood vessels
Improves the body’s ability to detoxify and inactivate or remove toxins
Activates cortisone-like molecules, sterols, into vitamin D
Restores normal size and movement of fat elements

Founder of VitaminDWiki wonders
Is the benefit due to creating Vitamin D directly in the blood?
If so, a 300 nm wavelength used to produce Vitamin D in the skin should be explored

UV Light does not get thru skin very far

Blood vessels are just below the dermis

 Download the PDF from VitaminDWiki

Ultraviolet blood irradiation (UBI) was extensively used in the 1940s and 1950s to treat many diseases including septicemia, pneumonia, tuberculosis, arthritis, asthma and even poliomyelitis. The early studies were carried out by several physicians in USA and published in the American Journal of Surgery. However with the development of antibiotics, the use of UBI declined and it has now been called “the cure that time forgot”. Later studies were mostly performed by Russian workers and in other Eastern countries, and the modern view in Western countries is that UBI remains highly controversial. This review discusses the potential of UBI as an alternative approach to current methods used to treat infections, as an immune-modulating therapy and as a method for normalizing blood parameters. Low and mild doses of UV kill microorganisms by damaging the DNA, while any DNA damage in host cells can be rapidly repaired by DNA repair enzymes. However the use of UBI to treat septicemia cannot be solely due to UV-mediated killing of bacteria in the bloodstream, as only 5–7% of blood volume needs to be treated with UV to produce the optimum benefit, and higher doses can be damaging. There may be some similarities to extracorporeal photopheresis (ECP) using psoralens and UVA irradiation. However there are differences between UBI and ECP in that UBI tends to stimulate the immune system, while ECP tends to be immunosuppressive. With the recent emergence of bacteria that are resistant to all known antibiotics, UBI should be more investigated as an alternative approach to infections, and as an immune-modulating therapy.

Sections of the PDF

Historical Introduction

Ultraviolet (UV) radiation is part of the electromagnetic spectrum with a wavelength range (100-400 nm) shorter than that of visible light (400-700 nm), but longer than x-rays (<100 nm). UV radiation is divided into four distinct spectral areas including vacuum UV (100-200 nm), UVC (200-280 nm), UVB (280-315 nm) and UVA (315-400 nm). Only part of UVB and UVA can reach on earth, because wavelengths shorter than 280 nm are filtered out by the atmosphere especially by the “ozone layer”.
In 1801 Johann Wilhelm Ritter, a Polish physicist working at the University of Jena in Germany discovered a form of light beyond the violet end of the spectrum that he called “Chemical Rays” and which later became “Ultraviolet” light [1]. In 1845, Bonnet [2] first reported that sunlight could be used to treat tuberculosis arthritis (a bacterial infection of the joints).
In the second half of the nineteenth century, the therapeutic application of sunlight known as heliotherapy gradually became popular. In 1855, Rikli from Switzerland opened a thermal station in Veldes in Slovenia for the provision of heliotherapy [3]. In 1877, Downes and Blunt discovered by chance that sunlight could kill bacteria [4]. They noted that sugar water placed on a window-sill turned cloudy in the shade but remained clear while in the sun. Upon microscopic examination of the two solutions, they realized that bacteria were growing in the shaded solution but not in the one exposed to sunlight.
In 1904, the Danish physician Niels Finsen was awarded the Nobel Prize in Physiology or Medicine for his work on UV treatment of various skin conditions. He had a success rate of 98% in thousands of cases, mostly the form of cutaneous tuberculosis known as lupus vulgaris [5]. Walter H Ude reported a series of 100 cases of erysipelas (a cutaneous infection caused by Streptococcus pyogenes) in the 1920s, with high cure rates using irradiation of the skin with UV light [6].
Emmett K Knott (Fig. 25.1) in Seattle, WA reasoned that the beneficial effects of UV irradiation to the skin obtained by Ude, might (at least partly) be explained by the irradiation of blood circulating in the superficial capillaries of the skin. With his collaborator Edblom, an irradiation chamber was constructed to allow direct exposure of the blood to UV. The irradiation chamber was circular and contained a labyrinthine set of channels that connected the inlet and outlet ports. All these channels were covered with a quartz window that formed the top of the chamber. The irradiation chamber was so designed as to provide maximum turbulence of the blood flowing through (see Fig. 25.2). This was done in order to: (a) prevent the formation of a thin film of blood on the chamber window that would absorb and filter out much of the UV light; (b) insure that all the blood passing through the chamber was equally exposed to UV [7].
Knott and co-workers then carried out a series of experiments using UV irradiation of blood extracted from dogs that had been intravenously infected with Staphylococcus aureus bacteria and hemolytic Streptococcus species, and then the treated blood was reinfused into the dogs. They found that it was unnecessary to deliver a sufficient exposure of UV light to the blood to directory kill all the bacteria in the circulation. It was also found unnecessary to expose the total blood volume in the dogs. The optimum amount of blood to be irradiated was determined to be only 5-7% of the estimated blood volume or approximately 3.5 mL per kg of body weight. Exceeding these limits led to loss of the benefits of the therapy. All the dogs that were treated with the optimized dose of UV to the blood, recovered from an overwhelming infection (while many dogs in the control group died). None of the dogs that were treated and survived, showed any long-term ill effects after 4 months of observation [7].
The first treatment on a human took place in 1928 when a patient was determined to be in a moribund state after a septic abortion complicated by hemolytic streptococcus septicemia. UBI therapy was commenced as a last resort, and the patient responded well to the treatment and made a full recovery [7]. She proceeded to give birth to two children.
Hancock and Knott [8] had similar success in another patient suffering from advanced hemo-lytic streptococcal septicemia. These workers noted that in the majority of cases, a marked cyanosis (blue tinge to the skin caused by a lack of oxygenated blood flow) was present at the time of initiation of UBI. It was noted that during (or immediately following) the treatment a rapid relief of the cyanosis occurred, with improvement in respiration accompanied by a noticeable flushing of the skin, with a distinct loss of pallor.
These observations led to application of UBI in patients suffering from pneumonia. In a series of 75 cases in which the diagnoses of pneumonia were confirmed by X-rays, all patients responded well to UBI showing a rapid decrease in temperature, disappearance of cyanosis (often within 3-5 min), cessation of delirium if present, a marked reduction in pulse rate and a rapid resolution of pulmonary consolidation. A shortening of the time of hospitalizations and accelerated convalescence was regularly observed.
The knowledge gained in these successful studies led to the redesign of the irradiation chamber to allow a more thoroughly uniform exposure of the circulating blood, and led to the development of the “Knott Technic of Ultraviolet Blood Irradiation.” A number of irradiation units were manufactured and placed in the hands of physicians interested in the procedure, so that more extensive clinical data could be accumulated [7]. The Knott technique involved removing approximately 3.5 mL/kg venous blood, titrating it as an anticoagulant, and passing it through the radiation chamber. The exposure time per given unit of blood was approximately 10 s, at a peak wavelength of 253.7 nm (ultraviolet C) provided by a mercury quartz burner, and the blood was immediately re-perfused [7].
George P Miley at the Hahnemann Hospital, Philadelphia, PA published a series of articles on the use of the procedure in the treatment of thrombophlebitis, staphylococcal septicemia, peritonitis, botulism, poliomyelitis, non-healing wounds, and asthma [9-22].
Henry A Barrett at the Willard Parker Hospital in New York City in 1940 reported on 110 cases including a number of different infections. Twenty- nine different conditions were described as being responsive, including the following: infectious arthritis, septic abortion, osteoarthritis, tuberculosis glands, chronic blepharitis, mastoiditis, uveitis, furunculosis, chronic paranasal sinusitis, acne vulgaris, and secondary anemia [23, 24].
EV Rebbeck at the Shadyside Hospital in Pittsburgh, PA, reported the use of UBI in Escherichia coli septicemia, post-abortion sepsis, puerperal sepsis, peritonitis, and typhoid fever [25-29] and Robert C Olney at the Providence Hospital, Lincoln, NE, treated biliary disease, pelvic cellulitis and viral hepatitis [30-32].
In this chapter, we will discuss the mechanisms and the potential of UBI as an alternative approach to infections and as a new method to modulate the immune system. Our goal is to remind people to continue to do more research and explore more clinical uses. The topics include the efficacy of UBI for infections (both bacterial and viral), to cure autoimmune disease, disease, and the similarities and differences between UBI, and intravenous ozone therapy, and extracorporeal psoralen-mediated photochemotherapy (photophoresis).

Conclusions Regarding Mechanisms

UBI has always caused much confusion, both in the general public and also in some medical professionals, because germicidal UV light (UVC) is used to sterilize water, disinfect surfaces, and as an aid to infection control in operating rooms, and food processing and packaging plants. Many people therefore assume that UBI must act by killing pathogens (bacteria, viruses or other microorganisms) circulating in the bloodstream. However there is no evidence that this is actually the case. Therefore the mechanisms of action must lie in some other action of UV on the various components of blood. Although the entire body of evidence on the mechanisms of action of UBI is very complex, as can be seen from the foregoing material, we can attempt to draw some general conclusions. Firstly UBI is clearly an example of the well-known phenomenon called “hormesis” or “biphasic dose response’. This phenomenon has been well reviewed by Edward Calabrese from U Mass Amherst [73, 74]. The basic concept states that any toxic chemical substance or drug, or any physical insult (such as ionizing radiation, hyperthermia, or oxidative stress) can be beneficial, protective or even therapeutic, provided the dose is low enough. If the dose is increased, the beneficial or protective effects disappear, and if the dose is even further increased, then the detrimental effects of the treatment become very evident. This is clearly shown by Knott’s original experiments on dogs that led to the establishment of only 5-7% of total blood volume as the optimal amount of blood to be irradiated.
UBI appears to have three broadly different classes of effects on different blood components. In the case of neutrophils, monocytes, macrophages, and dendritic cells, UBI can activate phagocytosis, increase the secretion of NO and reactive nitrogen species, and convert the DC phenotype from an immunogenic one into a tolerogenic one, thus perhaps lessening the effects of a “cytokine storm” as is often found in sepsis. In the case of lymphocytes, the effects of UBI are to inhibit (or in fact kill) various classes of lymphocytes. This is not perhaps very surprising, considering the well-established cell-death pathways and apoptotic signaling found in lymphocytes. However it is not impossible, that the killing of circulating lymphocytes could reduce systemic inflammation, which would again be beneficial in cases of sepsis. It is also clear that UBI can oxidize blood lipids and lipoproteins, and therefore increase oxidative stress. However it is also possible that a brief burst of oxidative stress, may be beneficial, whereas continued chronic levels of oxidative stress have been generally considered as detrimental. Many antioxidant defenses are up- regulated by brief exposure to oxidative stress, and this has been postulated to be one of the fundamental mechanisms responsible for may aspects of hormesis. The oxidative nature of UBI has encouraged us to draw parallels with ozone therapy and other forms of ‘oxygen therapy”.

Modern Devices to Carry Out UBI

Although it is often said that UBI is “the cure that time forgot” [90, 91], it has not actually been completely forgotten. There are several companies, organizations and devices existing at the present time, which are being used or proposed (on a rather small scale) to carry out UBI, or as it often called “Photoluminescence Therapy (PT)”. Several websites provide information on UBI and PT. Perhaps one of the most comprehensive is (http://www.mnwelldir.org/docs/uv_light/uv_ light3.htm) that provides a listing of practitioners located in USA that offer UBI to patients. UBI medical (http://ubimedical.com/about-us.html) also has a lot of information available. The website entitled “Infections cured” (http://infections- cured.com) is also worth checking out. Physicians UBI Awareness Center (http://drsubi.com) even has a video posted online comparing different kinds of UBI machines.


UV irradiation of blood was hailed as a miracle therapy for treating serious infections in the 1940s and 1950s. In an ironic quirk of fate, this historical time period coincided with the widespread introduction of penicillin antibiotics, which were rapidly found to be an even bigger medical miracle therapy. Moreover another major success of UBI, which was becoming increasingly used to treat polio, was also eclipsed by the introduction of the Salk polio vaccine in 1955 [91]. UBI had originally been an American discovery, but then was transitioned to being more studied in Russia and other eastern countries, which had long concentrated on physical therapies for many diseases, which were more usually treated with drugs in the West.
However in the last decade the problem of multi-antibiotic resistant bacteria has grown relentlessly. Multidrug-resistant (MDR) and pandrug resistant (PDR) bacterial strains and their related infections are emerging threats to public health throughout the world [92]. These are associated with approximately two-fold higher mortality rates and considerably prolonged hospital admissions [93]. The infections caused by antibiotic resistant strains are often exceptionally hard to treat due to the limited range of therapeutic options [94]. Recently in Feb 2015, the Review on Antimicrobial Resistance stated “Drug-resistant infections could kill an extra 10 million people across the world every year by 2050 if they are not tackled. By this date they could also cost the world around $100 trillion in lost output: more than the size of the current world economy, and roughly equivalent to the world losing the output of the UK economy every year, for 35 years” [95].
Sepsis is an uncontrolled response to infection involving massive cytokine release, widespread inflammation, which leads to blood clots and leaky vessels. Multi-organ failure can follow. Every year, severe sepsis strikes more than a million Americans. It is estimated that between 28-50% percent of these people die. Patients with sepsis are usually treated in hospital intensive care units with broad-spectrum antibiotics, oxygen and intravenous fluids to maintain normal blood oxygen levels and blood pressure. Despite decades of research, no drugs that specifically target the aggressive immune response that characterizes sepsis have been developed.
We would like to propose that UBI be reconsidered and re-investigated as a treatment for systemic infections caused by multi-drug resistant Gram-positive and Gram-negative bacteria in patients who are running out of (or who have already run out) of options. Patients at risk of death from sepsis could also be considered as candidates for UBI. Further research is required into the mechanisms of action of UBI. The present confusion about exactly what is happening during and after the treatment is playing a large role in the controversy about whether UBI could ever be a mainstream medical therapy, or must remain side-lined in the “alternative and complementary” category where it has been allowed to be forgotten for the last 50 years.


  1. Frercksa J, Weberb H, Wiesenfeldt G (2009) Reception and discovery: the nature of Johann Wilhelm Ritter’s invisible rays. Stud Hist Philos Sci Part A 40:143-156
  2. Bonnet A (1845) Traite des Maladies des Articulations. Bailliere, Paris
  3. Barth J, Kohler U (1992) Photodermatologie in Dresden-ein historischer Abriss. Festschrift anlasslich des 75. Geburtstages von Prof. Dr. Dr. Dr. h.c. H.-E. Kleine-Natrop (1917-1985). Dresden
  4. Downes A, Blunt TP (1877) Researches on the effect of light upon bacteria and other organisms. Proc R Soc Lond 26:488-500
  5. Finsen NR (1901) Phototherapy. Edward Arnold, London
  6. Ude WH (1929) Ultraviolet radiation therapy in ery- sipela. Radiology 13:504
  7. Knott EK (1948) Development of ultraviolet blood irradiation. Am J Surg 76(2):165-171
  8. Hancock VK, Knott EK (1934) Irradiated blood transfusion in the treatment of infections. Northwest Med 200(33)
  9. Miley G, Christensen JA (1947) Ultraviolet blood irradiation further studies in acute infections. Am J Surg LxxIII(4):486-493
  10. Miley G Uv irradiation non healing wounds. Am J Surg LXV(3):368-372, 1944
  11. Miley GP (1946) Recovery from botulism coma following ultraviolet blood irradiation. Rev Gastroenterol 13:17-19
  12. Miley GP, Seidel RE, Christensen JA (1946) Ultraviolet blood irradiation therapy of apparently intractable bronchial asthma. Arch Phys Med Rehabil 27:24-29
  13. Miley G (1943) The control of acute thrombophlebitis with ultraviolet blood irradiation therapy. Am J Surg 60:354-360
  14. Miley G (1944) Efficacy of ultraviolet blood irraidation therapy in the control of staphylococcemias. Am J Surg 64:313-322
  15. Miley G (1944) Ultraviolet blood irraidation therapy in acute poliomyelitis. Arch Phys Ther 25:651-656
  16. Miley G (1943) Disapperance of hemolytic staphylococcus aureus septicemia following ultraviolet blood irradiation therapy. Am J Surg 62:241-245
  17. Miley G (1942) The knott technic of ultraviolet blood irradiation in acute pyogenic infections. New York state Med 42:38-46
  18. Miley G (1944) Present status of ultraviolet blood irradiation (Knott technic). Arch Phys Ther 25:368-372
  19. Miley G (1942) Ultravilet blood irradiation. Arch Phys Ther 536(23)
  20. Miley G (1942) Ultraviolet blood irradiation therapy (knott technic) in acute pyogenic infections. Am J Surg 493(57)
  21. Miley G (1943) The knott technic of ultraviolet blood irradiation as a control of infection in peritonitis. Rev Gastroenterol 1(10)
  22. Miley GP, Seidel, R.E, Christensen, J.A (1943) Preliminary report of results observed in eighty cases of intractable bronchial asthma. Arch Phys Ther 533(24)
  23. Barrett HA (1940) The irradiation of autotransfused blood by ultraviolet spectral energy. Result of therapy in 110 cases. Med clin N Am 721(24):1040
  24. Barrett HA (1943) Five years’ experience with hemo- irradiation according to the Knott technic. Am J Surg 61(1):42-53
  25. Rebbeck EW (1942) Double septicemia following prostatectomy treated by the knott technic of ultraviolet blood irradiation. Am J Surg 57(3):536-538
  26. Rebbeck EW (1943) Preoperative hemo-irradiations. Am J Surg 61(2):259-265
  27. Rebbeck EW (1941) Ultraviolet irradiation of auto- transfused blood in the treatment of puerperal sepsis. Am J Surg 54(3):691-700
  28. Rebbeck EW (1942) Ultraviolet irradiation of auto- transfused blood in the treatment of postabortional sepsis. Am J Surg 55(3):476-486
  29. Rebbeck EW (1943) Ultraviolet irradiation of blood in the treatment of escherichia coli septicemia. Arch Phys Ther 24:158-167
  30. Olney RC (1946) Ultraviolet blood irradiation in biliary disease; Knott method. Am J Surg 72:235-237
  31. Olney RC (1947) Ultraviolet blood irradiation treatment of pelvic cellulitis; Knott method. Am J Surg 74(4):440-443
  32. Olney RC (1955) Treatment of viral hepatitis with the Knott technic of blood irradiation. Am J Surg 90(3):402-409
  33. Kabat IA, Sysa J, Zakrzewska I, Leyko W (1976) Effect of UV-irradiation of shifts of energy-rich phosphate compounds: ADP, ATP and AXP in human red blood cells represented by a trigonometrical polynomial. Zentralbl Bakteriol Orig B 162(3-4):393-401
  34. Vasil'eva ZF, Samoilova KA, Shtil'bans VI, Obolenskaia KD, Vitiuk NG (1991) Changes of immunosorption properties in the blood and its components at various times after UV-irradiation. Gematol Transfuziol 36(5):26-27
  35. Samoilova KA, Snopov SA, Belisheva NK, Kukui LM, Ganelina IE (1987) Functional and structural changes in the surface of human erythrocytes after irradiation by different wave lengths of UV rays.
  36. The immediate effect of the autotransfusion of UV-irradiated blood. Tsitologiia 29(7):810-817
  37. Snopov SA, Aritsishevskaia RA, Samoilova KA, Marchenko AV, Dutkevich IG (1989) Functional and structural changes in the surface of human erythrocytes following irradiation with ultraviolet rays of various wave lengths. V. Modification of the glyco- calyx in autotransfusions of UV-irradiated blood. Tsitologiia 31(6):696-705
  38. Ichiki H, Sakurada H, Kamo N, Takahashi TA, Sekiguchi S (1994) Generation of active oxygens, cell deformation and membrane potential changes upon
  39. UV-B irradiation in human blood cells. Biol Pharm Bull 17(8):1065-1069
  40. Savage JE, Theron AJ, Anderson R (1993) Activation of neutrophil membrane-associated oxidative metabolism by ultraviolet radiation. J Invest Dermatol 101(4):532-536
  41. Ivanov EM, Kapshienko IN, Tril NM (1989) Effect of the UV irradiation of autologous blood on the humoral link in the immune response of patients with chronic inflammatory processes. Vopr Kurortol Fizioter Lech Fiz Kult 1:45-47
  42. Artiukhov VF, Gusinskaia VV, Mikhileva EA (2005) Level of nitric oxide and tumor necrosis factor- alpha production by human blood neutrophils under UV-irradiation. Radiats Biol Radioecol 45(5):576-580
  43. Zor’kina AV, Inchina VI, Kostin Ia V (1996) Effect of UV-irradiation of blood on the course of adaptation to conditions of hypodynamia. Patol Fiziol Eksp Ter 2:22-24
  44. Deeg HJ (1988) Ultraviolet irradiation in transplantation biology. Manipulation of immunity and immuno- genicity. Transplantation 45(5):845-851
  45. Arlett CF, Lowe JE, Harcourt SA et al (1993) Hypersensitivity of human lymphocytes to UV-B and solar irradiation. Cancer Res 53(3):609-614
  46. Teunissen MB, Sylva-Steenland RM, Bos JD (1993) Effect of low-dose ultraviolet-B radiation on the function of human T lymphocytes in vitro. Clin Exp Immunol 94(1):208-213
  47. Schieven GL, Ledbetter JA (1993) Ultraviolet radiation induces differential calcium signals in human peripheral blood lymphocyte subsets. J Immunother Emphasis Tumor Immunol 14(3):221-225
  48. Spielberg H, June CH, Blair OC, Nystrom-Rosander C, Cereb N, Deeg HJ (1991) UV irradiation of lymphocytes triggers an increase in intracellular Ca2+ and prevents lectin-stimulated Ca2+ mobilization: evidence for UV- and nifedipine-sensitive Ca2+ channels. Exp Hematol 19(8):742-748
  49. Pamphilon DH, Corbin SA, Saunders J, Tandy NP (1989) Applications of ultraviolet light in the preparation of platelet concentrates. Transfusion 29(5):379-383
  50. Lindahl-Kiessling K, Safwenberg J (1971) Inability of UV-irradiated lymphocytes to stimulate allogeneic cells in mixed lymphocyte culture. Int Arch Allergy Appl Immunol 41(5):670-678
  51. Slater LM, Murray S, Liu J, Hudelson B (1980) Dissimilar effects of ultraviolet light on HLA-D and HLA-DR antigens. Tissue Antigens 15(5):431-435
  52. Aprile J, Deeg HJ (1986) Ultraviolet irradiation of canine dendritic cells prevents mitogen-induced cluster formation and lymphocyte proliferation. Transplantation 42(6):653-660
  53. Kovacs E, Weber W, Muller H (1984) Age-related variation in the DNA-repair synthesis after UV-C irradiation in unstimulated lymphocytes of healthy blood donors. Mutat Res 131(5-6):231-237
  54. Genter EI, Zhestianikov VD, Mikhel'son VM, Prokof’eva VV (1984) DNA repair in the UV irradiation of human peripheral blood lymphocytes (healthy donors and xeroderma pigmentosum patients) in relation to the dedifferentiation process in phytohemagglutinin exposure. Tsitologiia 26(5):599-604
  55. Genter EI, Mikhel’son VM, Zhestianikov VD (1989) The modifying action of methylmethane sulfonate on unscheduled DNA synthesis in the UV irradiation of human peripheral blood lymphocytes. Radiobiologiia 29(4):562-564
  56. Volgareva EV, Volgarev AP, Samoilova KA (1990) The effect of UV irradiation and of UV-irradiated autologous blood on the functional state of human peripheral blood lymphocytes. Tsitologiia 32(12):1217-1224
  57. Deeg HJ, Aprile J, Graham TC, Appelbaum FR, Storb R (1986) Ultraviolet irradiation of blood prevents transfusion-induced sensitization and marrow graft rejection in dogs. Blood 67(2):537-539
  58. Oluwole SF, Iga C, Lau H, Hardy MA (1985) Prolongation of rat heart allografts by donor-specific blood transfusion treated with ultraviolet irradiation. J Heart Transplant 4(4):385-389
  59. Vasil’eva ZF, Shtil'bans VI, Samoilova KS, Obolenskaia KD (1989) The activation of the immu- nosorptive properties of blood during its UV irradiation at therapeutic doses. Biull Eksp Biol Med 108(12):689-691
  60. Green MH, Waugh AP, Lowe JE, Harcourt SA, Cole J, Arlett CF (1994) Effect of deoxyribonucleosides on the hypersensitivity of human peripheral blood lymphocytes to UV-B and UV-C irradiation. Mutat Res 315(1):25-32
  61. Samoilova KA, Obolenskaia KD, Freidlin IS (1987) Changes in the leukocyte phagocytic activity of donor blood after its UV irradiation. II. Simulation of the effect of the autotransfusion of UV-irradiated blood. Tsitologiia 29(9):1048-1055
  62. Obolenskaia KD, Freidlin IS, Samoilova KA (1987) Changes in the leukocyte phagocytic activity of donor blood after its UV irradiation. I. Its relation to the irradiation dose and initial level of phagocytic activity. Tsitologiia 29(8):948-954
  63. Simon JC, Tigelaar RE, Bergstresser PR, Edelbaum D, Cruz PD Jr (1991) Ultraviolet B radiation converts Langerhans cells from immunogenic to tolerogenic antigen-presenting cells. Induction of specific clonal anergy in CD4+ T helper 1 cells. J Immunol 146(2):485-491
  64. Pamphilon DH, Potter M, Cutts M et al (1990) Platelet concentrates irradiated with ultraviolet light retain satisfactory in vitro storage characteristics and in vivo survival. Br J Haematol 75(2):240-244
  65. Fiebig E, Lane TA (1994) Effect of storage and ultraviolet B irradiation on CD14-bearing antigen- presenting cells (monocytes) in platelet concentrates. Transfusion 34(10):846-851
  66. Kahn RA, Duffy BF, Rodey GG (1985) Ultraviolet irradiation of platelet concentrate abrogates lymphocyte activation without affecting platelet function in vitro. Transfusion 25(6):547-550
  67. Andreu G, Boccaccio C, Klaren J et al (1992) The role of UV radiation in the prevention of human leukocyte antigen alloimmunization. Transfus Med Rev 6(3):212-224
  68. Tandy NP, Pamphilon DH (1991) Platelet transfusions irradiated with ultraviolet-B light may have a role in reducing recipient alloimmunization. Blood Coagul Fibrinolysis 2(2):383-388
  69. Roshchupkin DI, Murina MA (1998) Free-radical and cyclooxygenase-catalyzed lipid peroxidation in membranes of blood cells under UV irradiation. Membr Cell Biol 12(2):279-286
  70. Gorog P (1991) Activation of human blood monocytes by oxidized polyunsaturated fatty acids: a possible mechanism for the generation of lipid peroxides in the circulation. Int J Exp Pathol 72(2):227-237
  71. Salmon S, Maziere JC, Santus R, Morliere P, Bouchemal N (1990) UVB-induced photoperoxidation of lipids of human low and high density lipoproteins. A possible role of tryptophan residues. Photochem Photobiol 52(3):541-545
  72. Salmon S, Haigle J, Bazin M, Santus R, Maziere JC, Dubertret L (1996) Alteration of lipoproteins of suction blister fluid by UV radiation. J Photochem Photobiol B 33(3):233-238
  73. Artyukhov VG, Iskusnykh AY, Basharina OV, Konstantinova TS (2005) Effect of UV irradiation on functional activity of donor blood neutrophils. Bull Exp Biol Med 139(3):313-315
  74. Dong Y, Shou T, Zhou Y, Jiang S, Hua X (2000) Ultraviolet blood irradiation and oxygenation affects free radicals and antioxidase after rabbit spinal cord injury. Chin Med J 113(11):991-995
  75. Calabrese EJ, Dhawan G, Kapoor R, Iavicoli I, Calabrese V (2015) HORMESIS: a fundamental concept with widespread biological and biomedical applications. Gerontology 62:530
  76. Calabrese EJ (2014) Hormesis: from mainstream to therapy. J Cell Commun Signal 8(4):289-291
  77. Zaky S, Kamel SE, Hassan MS et al (2011) Preliminary results of ozone therapy as a possible treatment for patients with chronic hepatitis C. J Altern Complement Med 17(3):259-263
  78. Edelson RL (2014) Mechanistic insights into extracorporeal photochemotherapy: efficient induction of monocyte-to-dendritic cell maturation. Transfus Apher Sci 50(3):322-329
  79. Child FJ, Ratnavel R, Watkins P et al (1999) Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD). Bone Marrow Transplant 23(9):881-887
  80. Atta M, Papanicolaou N, Tsirigotis P (2012) The role of extracorporeal photopheresis in the treatment of cutaneous T-cell lymphomas. Transfus Apher Sci 46(2):195-202
  81. De Waure C, Capri S, Veneziano MA et al (2015) Extracorporeal Photopheresis for second-line treatment of chronic graft-versus-host diseases: Results from a health technology assessment in Italy. Value Health 18(4):457-466
  82. Patel J, Klapper E, Shafi H, Kobashigawa JA (2015) Extracorporeal photopheresis in heart transplant rejection. Transfus Apher Sci 52(2):167-170
  83. Reinisch W, Knobler R, Rutgeerts PJ et al (2013) Extracorporeal photopheresis (ECP) in patients with steroid-dependent Crohn’s disease: an open-label, multicenter, prospective trial. Inflamm Bowel Dis 19(2):293-300
  84. Ludvigsson J, Samuelsson U, Ernerudh J, Johansson C, Stenhammar L, Berlin G (2001) Photopheresis at onset of type 1 diabetes: a randomised, double blind, placebo controlled trial. Arch Dis Child 85(2):149-154
  85. Edelson R, Berger C, Gasparro F et al (1987) Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. N Engl J Med 316(6):297-303
  86. Wollina U, Looks A, Meyer J et al (2001) Treatment of stage II cutaneous T-cell lymphoma with interferon alfa-2a and extracorporeal photochemotherapy: a prospective controlled trial. J Am Acad Dermatol 44(2):253-260
  87. Niggli HJ, Rothlisberger R (1988) Cyclobutane-type pyrimidine photodimer formation and induction of ornithine decarboxylase in human skin fibroblasts after UV irradiation. J Invest Dermatol 91(6):579-584
  88. Vendrell-Criado V, Rodriguez-Muniz GM, Lhiaubet- Vallet V, Cuquerella MC, Miranda MA (2016) The (6-4) Dimeric Lesion as a DNA Photosensitizer. Chem Phys Chem 17(13):1979-1982
  89. Santella RM, Dharmaraja N, Gasparro FP, Edelson RL (1985) Monoclonal antibodies to DNA modified by 8-methoxypsoralen and ultraviolet A light. Nucleic Acids Res 13(7):2533-2544
  90. Heald P, Rook A, Perez M et al (1992) Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy. J Am Acad Dermatol 27(3):427-433
  91. Hart JW, Shiue LH, Shpall EJ, Alousi AM (2013) Extracorporeal photopheresis in the treatment of graft-versus-host disease: evidence and opinion. Ther Adv Hematol 4(5):320-334
  92. Rowen RJ (1996) Ultraviolet blood irradiation therapy (Photo-Oxidation) the cure that time forgot. Int J Biosocial Med Research 14(2):115-132
  93. Wu X, Hu X, Hamblin MR (2016) Ultraviolet blood irradiation: is it time to remember “the cure that time forgot”? J Photochem Photobiol B 157:89-96
     Download the PDF from VitaminDWiki
  94. Kraus CN (2008) Low hanging fruit in infectious disease drug development. Curr Opin Microbiol 11(5):434-438
  95. Munoz-Price LS, Poirel L, Bonomo RA et al (2013) Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 13(9):785-796
  96. Yoneyama H, Katsumata R (2006) Antibiotic resistance in bacteria and its future for novel antibiotic development. Biosci Biotechnol Biochem 70(5):1060-1075
  97. O'neill J (2015) Review on antimicrobial resistance: tackling a global health crisis. Initial Steps

Created by admin. Last Modification: Saturday November 11, 2017 20:34:06 GMT-0000 by admin. (Version 12)

Attached files

ID Name Comment Uploaded Size Downloads
8717 Skin crossection.jpg admin 11 Nov, 2017 28.14 Kb 2814
8716 UV thru skin.jpg admin 11 Nov, 2017 61.60 Kb 2716
8715 Time forgot.pdf admin 11 Nov, 2017 1.38 Mb 1155
8714 UVI3.jpg admin 11 Nov, 2017 10.28 Kb 2540
8713 UVI2.jpg admin 11 Nov, 2017 26.28 Kb 14206
8712 UVI1.jpg admin 11 Nov, 2017 35.76 Kb 4822
8711 711-Blood UV irradiation Hamblin.pdf admin 11 Nov, 2017 550.11 Kb 4223